Guest guest Posted September 19, 2011 Report Share Posted September 19, 2011 Tekmira and Collaborators Demonstrate Efficacy of RNAi Against Hepatitis C Virus From the PharmaLive.com News Archive - Sep. 14, 2011 Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, announced today a presentation of data demonstrating, for the first time, in vivo efficacy of RNAi against the Hepatitis C virus (HCV). Quote Link to comment Share on other sites More sharing options...
Guest guest Posted September 19, 2011 Report Share Posted September 19, 2011 Tekmira and Collaborators Demonstrate Efficacy of RNAi Against Hepatitis C Virus From the PharmaLive.com News Archive - Sep. 14, 2011 Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, announced today a presentation of data demonstrating, for the first time, in vivo efficacy of RNAi against the Hepatitis C virus (HCV). Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.